REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
33,920,691
Share change
+3,377,341
Total reported value
$1,405,622,268
Put/Call ratio
121%
Price per share
$41.44
Number of holders
192
Value change
+$144,432,379
Number of buys
115
Number of sells
58

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2017

As of 30 Jun 2017, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 192 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,920,691 shares. The largest 10 holders included BlackRock Inc., TimesSquare Capital Management, LLC, VANGUARD GROUP INC, OppenheimerFunds, Inc., Invesco Ltd., FMR LLC, Conestoga Capital Advisors, LLC, STATE STREET CORP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and Ranger Investment Management, L.P.. This page lists 193 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.